"Interleukin-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes.
| Descriptor ID |
D007376
|
| MeSH Number(s) |
D12.644.276.374.465.021 D12.644.276.374.480.372 D12.776.467.374.465.021 D12.776.467.374.480.372 D23.529.374.465.155 D23.529.374.480.372
|
| Concept/Terms |
Interleukin-2- Interleukin-2
- Interleukin 2
- IL-2
- IL2
- TCGF
- Interleukine 2
- Lymphocyte Mitogenic Factor
- Mitogenic Factor, Lymphocyte
- T-Cell Growth Factor
- T Cell Growth Factor
- T-Cell Stimulating Factor
- T Cell Stimulating Factor
- Thymocyte Stimulating Factor
- Interleukin II
Ro-23-6019- Ro-23-6019
- Ro 23 6019
- Ro236019
- Ro-236019
- Ro 236019
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-2".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-2".
This graph shows the total number of publications written about "Interleukin-2" by people in this website by year, and whether "Interleukin-2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 2 | 4 |
| 1996 | 3 | 10 | 13 |
| 1997 | 6 | 5 | 11 |
| 1998 | 3 | 0 | 3 |
| 1999 | 2 | 4 | 6 |
| 2000 | 1 | 3 | 4 |
| 2001 | 3 | 4 | 7 |
| 2002 | 3 | 6 | 9 |
| 2003 | 2 | 4 | 6 |
| 2004 | 4 | 7 | 11 |
| 2005 | 1 | 3 | 4 |
| 2006 | 3 | 6 | 9 |
| 2007 | 2 | 3 | 5 |
| 2008 | 2 | 1 | 3 |
| 2009 | 3 | 2 | 5 |
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 5 | 6 |
| 2012 | 1 | 2 | 3 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 3 | 3 |
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 3 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-2" by people in Profiles.
-
A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):299-307.
-
BiTE secretion by adoptively transferred stem-like T cells improves FRa+ ovarian cancer control. J Immunother Cancer. 2023 06; 11(6).
-
Reduced Satb1 expression predisposes CD4+ T conventional cells to Treg suppression and promotes transplant survival. Proc Natl Acad Sci U S A. 2022 10 04; 119(40):e2205062119.
-
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. J Clin Oncol. 2022 12 10; 40(35):4107-4118.
-
A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells. Cell. 2021 07 22; 184(15):3981-3997.e22.
-
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. Clin Cancer Res. 2021 04 15; 27(8):2179-2189.
-
Landscape of stimulation-responsive chromatin across diverse human immune cells. Nat Genet. 2019 10; 51(10):1494-1505.
-
Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells. Sci Immunol. 2019 09 13; 4(39).
-
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019 08; 5(8):eaaw7756.
-
Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Sci Transl Med. 2019 04 10; 11(487).